Loading…
Baronsmead VCT reports 7.1% NAV dip amid market volatility, highlighting resilient unquoted holdings while navigating AIM sector challenges. New investments continue.
This article covers information on Baronsmead Second Venture Trust PLC.
LON:BMDLet’s cut straight to it: Baronsmead Second Venture Trust (BSVT) just reported a 7.1% drop in net asset value (NAV) per share for the six months to March 2025. That’s not a typo, and it’s certainly not business-as-usual for this stalwart of the VCT scene. The NAV slid from 55.2p to 51.3p, before ticking up to 54.1p by end-May. What’s behind the stumble? Buckle up – we’ve got political drama, market tremors, and a classic tale of public vs private equity resilience.
First, the headline stats:
The real story? That 7.1% drop wasn’t random noise. It was a tale of two portfolios…
Chair Sarah Fromson didn’t mince words: the “period of domestic and global political uncertainty” post-November 2024 (yes, that US election) hammered sentiment. But here’s where BSVT’s hybrid structure proved its mettle:
Flat as a pancake. Zero change in value. Why? Sheer diversification. 35% of holdings gained value (notably CitySwift and Panthera Biopartners), 35% held steady, and 30% dipped (Orri and Huma Therapeutics struggled with “extending sales cycles” – govt spending sectors like health felt the pinch). This is private equity’s superpower: insulation from daily market hysterics.
Ouch. Direct AIM holdings plunged 11.6% (vs AIM index -7.1%). The WS Gresham House funds took hits too: UK Micro Cap (-3.5%), Smaller Companies (-7.5%), Multi Cap Income (-11.5%). Blame? “National insurance and minimum wage increases” squeezing UK small-caps, despite >80% of portfolio companies meeting/exceeding expectations. Brutal.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
31 viewsLikes
No ratings yet
Last updated:
Occasional emails on automation, AI and finance. Unsubscribe any time.
Silver lining: Post-March, AIM holdings rebounded +4.8% in April (vs AIM +1.5%) and +5.3% in May. Volatility cuts both ways.
While markets wobbled, BSVT kept investing – strategically:
This isn’t reckless optimism. It’s the VCT playbook: deploy during downturns to capture value. As Fromson notes, this environment offers “high quality investments… at good prices.”
Exits were muted but telling:
Translation: Managers harvested gains where possible but avoided fire sales. That Cerillion return? A reminder why we stomach the volatility.
Despite the NAV dip, investor appetite held firm:
The Board’s buyback policy (capping discounts at 5%) signals confidence – and liquidity matters in choppy markets.
Fromson’s crystal ball is refreshingly candid:
Her verdict? “We remain committed to investing through the economic cycle.” Translation: Volatility isn’t an exit signal – it’s an entry point for disciplined VCTs.
BSVT’s half-year reads like a masterclass in VCT reality: NAVs wobble, small-caps suffer whiplash, but well-structured portfolios weather storms. The 7.1% dip stings, but look deeper:
This isn’t a panic signal – it’s a reminder that VCT investing rewards marathon runners, not sprinters. As the trust navigates Labour’s Autumn Budget and Trump-era trade wars, that hybrid portfolio isn’t just diversification… it’s armour.
Disclosure: This is commentary, not advice. Always dig into the full RNS before any investment decision.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.